Pulmonary Regurgitation clinical trials at UC Health
2 in progress, 1 open to eligible people
open to all eligible people
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
at UCLA UCSF
Sorry, in progress, not accepting new patients
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system.